JPRN-UMIN000013219已完成1 期
Phase I/II trial of nab-PTX/CDGP for chemo-naive patients with advanced squamous cell lung cancer (KRSG-1302) - Phase I/II trial of nab-PTX/CDGP for patients with advanced squamous cell lung cancer (KRSG-1302)
Kanto respiratory disease study group0 个研究点目标入组 23 人开始时间: 2014年2月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Symptomatic brain metastasis 2) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 3) With active double cancer or multicentric cancer 4) .>= G2 peripheral neuropathy (CTCAE) 5) Treated with radiotherapy within the past four weeks. 6) With clinically important complications. 7) Interstitial pneumonia or pulmonary fibrosis becomes the clinical problem 8) With pleural effusion or pericardial effusion accumulates which need drainage 9) With the history of hypersensivity for component of human plasma with albumin, nab-PTX, or CDGP 10) Main organs had a serious medical risk factor, and the physicians judged treatment not to be safe. 11) Physician concludes that the patient's participation in this trial is inappropriate
研究者
相似试验
已完成
不适用
Clinical efficacy of nab-PTX+GEM chemotherapy plus zoledronate- activated autologous killer lymphocytes (ZAK cells) in patients with unresectable or recurrent pancreas cancerChemotherapy-naive unresectable or recurrent pancreatic cancerJPRN-UMIN000021827Kawasaki Medical School Department of Clinical Oncology60
已完成
不适用
Clinical efficacy of nab-PTX+GEM chemotherapy plus zoledronate- activated autologous killer lymphocytes (ZAK cells) in patients with unresectable or recurrent pancreas cancerChemotherapy-naive unresectable or recurrent pancreatic cancerJPRN-UMIN000041683Kawasaki Medical School Department of Clinical Oncology60
招募中
1 期
Phase I/II trial of combined chemotherapy of Nab-paclitaxel, S-1, and Oxaliplatin for gastric cancer patients with peritoneal metastasis (NSOX study)gastric cancer with peritoneal metastasisJPRN-UMIN000030909Wakayama Medical University, School of Medicine35
已完成
2 期
eoadjuvant chemotherapy in patients with locally advanced and /or nodal positive gastric cancer with Docetaxel, Cisplatin and 5-Focally advanced and/or nodal positive gastric cancer (UICC Stages: IIIa, IIIb, IV M0)Malignant neoplasm of stomachCancerISRCTN43859589Medical University of Greifswald (Germany)46
已完成
2 期
A phase II trial of Down staging Chemotherapy with Nab-paclitaxel plus Gemcitabine in patients with locally advanced pancreatic cancerlocally advanced pancreatic cancerJPRN-UMIN000022241Chiba study group of adjuvant chemotherapy for pancreatic cancer40